BÜCHER VERSANDKOSTENFREI INNERHALB DEUTSCHLANDS
Adapting to Change
Federal Policy Dynamics and the Pharmaceutical Industry
Taylor & Francis Ltd
ISBN 978-1-04-115981-0
Standardpreis
Bibliografische Daten
Buch. Hardcover
2025
16 Farbabbildungen, 16 Farbfotos, 7 s/w-Tabelle.
Umfang: 120 S.
Format (B x L): 13.8 x 21.6 cm
Verlag: Taylor & Francis Ltd
ISBN: 978-1-04-115981-0
Produktbeschreibung
The US pharmaceutical landscape is in the midst of impactful shifts. A series of ambitious, aggressive, and often interconnected federal policy changes—from direct drug price controls and sweeping Pharmacy Benefit Manager reforms to strategic initiatives to reshore manufacturing and rapidly evolving FDA approaches—is creating a new reality for industry leaders, innovators, and strategists. In this analysis, a federal policy expert unpacks the complex forces reshaping how life-saving therapies are researched, developed, manufactured, and delivered.
Key Features
•Understand the Interconnectedness of U.S. Federal Policies.
•Analyze the Strategic Impacts of Key Legislation and Executive Actions.
•Evaluate Challenges and Opportunities in a Dynamic Regulatory Environment.
•Analyze the Interplay of U.S. Federal Actions and Industry Operations.
•Formulate Adaptive Strategies for Industry Resilience.
Key Features
•Understand the Interconnectedness of U.S. Federal Policies.
•Analyze the Strategic Impacts of Key Legislation and Executive Actions.
•Evaluate Challenges and Opportunities in a Dynamic Regulatory Environment.
•Analyze the Interplay of U.S. Federal Actions and Industry Operations.
•Formulate Adaptive Strategies for Industry Resilience.
Autorinnen und Autoren
Produktsicherheit
Hersteller
Libri GmbH
Europaallee 1
36244 Bad Hersfeld, DE
gpsr@libri.de
Rezensionen
